← Acadia Healthcare Company, Inc. ACHC
Market Price
$30.82
Market Cap
$2.78B
P/E Ratio
N/A
Revenue (FY 2025)
↑5.0% YoY
$3.31B
3-Yr CAGR: 8.3%
Net Income
↓-531.4% YoY
-$1.10B
Net Margin: -33.3%
Free Cash Flow
↑21.5% YoY
-$439.91M
FCF Yield: -15.82%
EPS (Diluted)
↓-537.4% YoY
$-12.16
Basic: $-12.16
Return on Equity
Efficiency
-56.6%
ROA: -135.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ACHC)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $-181.3M | — | — | $6.1M | — | $0.07 | — | $361.5M | $54.0M | — |
| FY 2017 | $-176.0M | +2.9% | — | $199.8M | +3,153.1% | $2.30 | +3,185.7% | $399.6M | $125.4M | +132.2% |
| FY 2018 | $3,012.4M | +1,811.5% | $680.2M | $-175.8M | -187.9% | $-2.01 | -187.4% | $414.1M | $72.6M | -42.1% |
| FY 2019 | $3,107.5M | +3.2% | $676.3M | $108.9M | +162.0% | $1.24 | +161.7% | $332.9M | $48.2M | -33.6% |
| FY 2020 | $2,089.9M | -32.7% | $130.6M | $-672.1M | -717.1% | $-7.59 | -712.1% | $658.8M | $442.2M | +817.0% |
| FY 2021 | $2,314.4M | +10.7% | $354.6M | $190.6M | +128.4% | $2.10 | +127.7% | $374.5M | $129.7M | -70.7% |
| FY 2022 | $2,610.4M | +12.8% | $475.0M | $273.1M | +43.3% | $2.98 | +41.9% | $380.6M | $84.4M | -34.9% |
| FY 2023 | $2,928.7M | +12.2% | $215.9M | $-21.7M | -107.9% | $-0.24 | -108.1% | $462.3M | $38.2M | -54.7% |
| FY 2024 | $3,154.0M | +7.7% | $422.1M | $255.6M | +1,279.7% | $2.78 | +1,258.3% | $129.7M | $-560.7M | -1,567.5% |
| FY 2025 | $3,312.8M | +5.0% | $3,312.8M | $-1,102.8M | -531.4% | $-12.16 | -537.4% | $131.9M | $-439.9M | +21.5% |
Valuation
Market Price
$30.82
Market Cap
$2.78B
Enterprise Value
$5.15B
P/E Ratio
N/A
P/B Ratio
1.45
FCF Yield
-15.82%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
100.00%
Operating Margin
-32.54%
Net Margin
-33.29%
Return on Equity (ROE)
-56.58%
Return on Assets (ROA)
-135.45%
Asset Turnover
4.07x
Revenue 3-Yr CAGR
8.27%
Financial Health & Liquidity
Current Ratio
1.55
Cash Ratio
0.25
Debt / Equity
1.283
Debt / Assets
3.071
Cash & Equivalents
$133.24M
Total Debt
$2.50B
Book Value / Share
$21.19
Cash Flow Efficiency
Operating Cash Flow
$131.90M
Capital Expenditures (CapEx)
$571.81M
Free Cash Flow
-$439.91M
OCF / Revenue
3.98%
FCF / Revenue
-13.28%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-12.16
EPS (Basic)
$-12.16
Dividends / Share
N/A
Book Value / Share
$21.19
EPS YoY Growth
-537.41%
Balance Sheet (FY 2025)
Total Assets
$814.14M
Total Liabilities
$525.19M
Stockholders' Equity
$1.95B
Current Assets
$814.14M
Current Liabilities
$525.19M